Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM) (SMA002)

This study has been completed.
Sponsor:
Collaborators:
Juvenile Diabetes Research Foundation
Becton, Dickinson and Company
Information provided by (Responsible Party):
Stacey Anderson, University of Virginia
ClinicalTrials.gov Identifier:
NCT01469715
First received: November 7, 2011
Last updated: January 30, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)